Daniel Skubleny

Dr. Daniel Skubleny

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2018 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
DSDaniel Skubleny
Daniel Skubleny
Jerry DangJerry Dang
Jerry Dang
SSSamuel Skulsky
Samuel Skulsky
NSNoah Switzer
Noah Switzer
CTChunhong Tian
Chunhong Tian
SKShahzeer Karmali
Shahzeer Karmali

1 May 2016 in Annals of Surgery
Verified
Journal Article
Closed access
NSNoah J. Switzer
Noah J. Switzer
SMShaheed Merani
Shaheed Merani
DSDaniel Skubleny
Daniel Skubleny
JPJean-Sébastien Pelletier
Jean-Sébastien Pelletier
RKRaisa Kanji
Raisa Kanji
SKShahzeer Karmali
Shahzeer Karmali
We aim to systematically review the bariatric surgery literature with regards to adequacy of patient follow-up, meeting the McMaster criteria of ≥80% follow-up. Loss to follow-up is a major concern and can potentially bias the outcome and interpretation of a study. The quality of follow-up in bariatric surgery is quite variable with recent systematic reviews criticizing the field for its lack of overall follow-up. A complete search of PubMed was performed. Literature was restricted to a range of 5 years (2007-2012), English language, and publications listed in PubMed. The McMaster Evidence-based Criteria for High Quality Studies was used to assess the follow-up data adequacy and a logistic meta-regression was performed to identify factors associated with high quality follow-up studies. Ninety-nine published manuscripts were included. For follow-up at study end, only 40/99 (40.4%) of papers had adequate patient follow-up, 42/99 (42.4%) failed to meet the McMaster criteria and 17/99 (17.2%) failed to report any follow-up results. On average, 31% were lost to follow-up at the study's end. Only shorter study duration, and if the study was performed in the US, were associated with studies meeting the McMaster criteria. Only 40% of studies in the bariatric surgery literature meet criteria for adequate follow-up. On average, studies have 30% of patients lost to follow-up at the stated end-point. Identified study characteristics associated with high quality follow-up included shorter study duration and studies performed in the US.

26 September 2024 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
DSDaniel Skubleny
Daniel Skubleny
KPKieran Purich
Kieran Purich
DMDavid R. McLean
David R. McLean
SMSebastiao N. Martins-Filho
Sebastiao N. Martins-Filho
KBKlaus Buttenschoen
Klaus Buttenschoen
GRGina R Rayat
Gina R Rayat
Purpose: We performed an integrated analysis of molecular classification systems proposed by The Cancer Genome Atlas (TCGA), the Asian Cancer Research Group (ACRG), and the tumor microenvironment (TME) score to identify which classification scheme(s) are most promising to pursue in subsequent translational investigations. Experimental Design: Supervised machine learning classifiers were created using 10-fold nested cross-validation for TCGA, ACRG, and TME subtypes and applied to 2,202 patients with gastric cancer from 11 separate publicly available datasets. Overall survival was assessed with a multivariable Cox proportional hazards model. A propensity score–matched analysis was performed to evaluate the subgroup effect of adjuvant chemotherapy on molecular subtypes. A public external cohort comprised of metastatic gastric cancer treated with immunotherapy was used to externally validate the molecular subtypes. Results: Classification models for TCGA, ACRG, and TME achieved an accuracy ± SD of 89.5% ± 0.04, 84.7% ± 0.04, and 89.3% ± 0.02, respectively. We identified the TME score as the only significantly prognostic classification system [HR, 0.54 (95% confidence interval [CI], 0.39–0.74); global Wald test P < 0.001]. In our subgroup analysis, patients who received adjuvant chemotherapy achieved greater survival with increasing TME score (HR, 0.47; 95% CI, 0.29–0.74; interaction P < 0.05). The combination of TME-high and microsatellite instability scores significantly outperformed microsatellite instability as a univariable predictor of immunotherapy response. Conclusions: We conclude that the TME score is a predominate driver of prognosis as well as chemotherapy- and immunotherapy-related outcomes in gastric cancer. This article provides a foundation for additional analyses and translational work.

15 February 2023 in World Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
DSDaniel Skubleny
Daniel Skubleny
ALAndrea Lin
Andrea Lin
SGSaurabh Garg
Saurabh Garg
RMRoss McLean
Ross McLean
MMMichael McCall
Michael McCall
GRGina Rayat
Gina Rayat
Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study

29 March 2024 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
DSDaniel Skubleny
Daniel Skubleny
SGSunita Ghosh
Sunita Ghosh
JSJennifer Spratlin
Jennifer Spratlin
DSDaniel E. Schiller
Daniel E. Schiller
GRGina R. Rayat
Gina R. Rayat
Background: Cross-platform normalization seeks to minimize technological bias between microarray and RNAseq whole-transcriptome data. Incorporating multiple gene expression platforms permits external validation of experimental findings, and augments training sets for machine learning models. Here, we compare the performance of Feature Specific Quantile Normalization (FSQN) to a previously used but unvalidated and uncharacterized method we label as Feature Specific Mean Variance Normalization (FSMVN). We evaluate the performance of these methods for bidirectional normalization in the context of nested feature selection. Results: FSQN and FSMVN provided clinically equivalent bidirectional model performance with and without feature selection for colon CMS and breast PAM50 classification. Using principal component analysis, we determine that these methods eliminate batch effects related to technological platforms. Without feature selection, no statistical difference was identified between the performance of FSQN and FSMVN of cross-platform data compared to within-platform distributions. Under optimal feature selection conditions, balanced accuracy was FSQN and FSMVN were statistically equivalent to the within-platform distribution performance in multivariable linear regression analysis. FSQN and FSMVN also provided similar performance to within-platform distributions as the number of selected genes used to create models decreases. Conclusions: In the context of generating supervised machine learning classifiers for molecular subtypes, FSQN and FSMVN are equally effective. Under optimal modeling conditions, FSQN and FSMVN provide equivalent model accuracy performance on cross-platform normalization data compared to within-platform data. Using cross-platform data should still be approached with caution as subtle performance differences may exist depending on the classification problem, training, and testing distributions.

15 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
DSDaniel Skubleny
Daniel Skubleny
JSJennifer Spratlin
Jennifer Spratlin
SGSunita Ghosh
Sunita Ghosh
RGRussell Greiner
Russell Greiner
DSDan Schiller
Dan Schiller
GRGina R Rayat
Gina R Rayat
Recent advances in our understanding of gastric cancer biology have prompted a shift towards more personalized therapy. However, results are based on population-based survival analyses, which evaluate the average survival effects of entire treatment groups or single prognostic variables. This study uses a personalized survival modelling approach called individual survival distributions (ISDs) with the multi-task logistic regression (MTLR) model to provide novel insight into personalized survival in gastric adenocarcinoma. We performed a pooled analysis using 1043 patients from a previously characterized database annotated with molecular subtypes from the Cancer Genome Atlas, Asian Cancer Research Group, and tumour microenvironment (TME) score. The MTLR model achieved a 5-fold cross-validated concordance index of 72.1 ± 3.3%. This model found that the TME score and chemotherapy had similar survival effects over the entire study time. The TME score provided the greatest survival benefit beyond a 5-year follow-up. Stage III and Stage IV disease contributed the greatest negative effect on survival. The MTLR model weights were significantly correlated with the Cox model coefficients (Pearson coefficient = 0.86, p < 0.0001). We illustrate how ISDs can accurately predict the survival time for each patient, which is especially relevant in cases of molecular subtype heterogeneity. This study provides evidence that the TME score is principally associated with long-term survival in gastric adenocarcinoma. Additional external validation and investigation into the clinical utility of this ISD model in gastric cancer is an area of future research.